PRKD1


Summary: The protein encoded by this gene is a serine/threonine protein kinase involved in many cellular processes, including Golgi body membrane integrity and transport, cell migration and differentiation, MAPK8/JNK1 and Ras pathway signaling, MAPK1/3 (ERK1/2) pathway signaling, cell survival, and regulation of cell shape and adhesion. [provided by RefSeq, Jan 2017].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:605435
PHARMGKB IDPA33771
Map Location14q12

GO terms in PRKD1


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IDA GO:0004674 protein serine/threonine kinase activity
MF IMP GO:0004674 protein serine/threonine kinase activity
MF TAS GO:0004674 protein serine/threonine kinase activity
MF IDA GO:0004697 protein kinase C activity
MF IPI GO:0005515 protein binding
MF IEA GO:0005524 ATP binding
Showing 1 to 6 of 67 rows rows per page

Gene expression in normal tissue: PRKD1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined52PI3K/MTOR signaling3Cell cycle2Apoptosis regulation2Biosynthesis of secondary metabolites2DNA replication2Ferroptosis1Protein stability and degradation1Chromatin histone acetylation1Mitosis1

Pathways in PRKD1


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-1430728 Metabolism
reactome R-HSA-1660661 Sphingolipid de novo biosynthesis
reactome R-HSA-428157 Sphingolipid metabolism
reactome R-HSA-556833 Metabolism of lipids
netpath Pathway_BCR BCR
netpath Pathway_EGFR1 EGFR1
Showing 1 to 6 of 20 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD506 Fedratinib 1
iGMDRD399 Selumetinib 2
iGMDRD356 PNU-74654 1
iGMDRD23 Gossypol 2
Showing 1 to 4 of 74 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in PRKD1

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​